One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...
Eli Lilly wants to take big swings in Alzheimer's, ALS, chronic pain and other difficult diseases after its success in ...
How can we best treat infectious diseases in people with obesity? Hospital pharmacist and Ph.D. researcher Koen van Rhee ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...
Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...
Scientists have found specialized neurons in the brains of mice that order the animals to stop eating. Though many feeding ...
Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...
Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...
In ongoing trials of Eli Lilly’s (LLY) next-generation obesity drug, several trial participants are losing too much weight, STAT’s Elaine Chen ...
As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...
Love Island star Shaughna Phillips has spoken about her experience with the condition that can leave sufferers ashamed and ...